Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 188.79 Million USD | 27.4% |
| 2023 | 148.18 Million USD | 69.7% |
| 2022 | 87.32 Million USD | -52.64% |
| 2021 | 184.36 Million USD | 156.46% |
| 2020 | 71.88 Million AUD | 90.88% |
| 2019 | 37.66 Million AUD | -18.26% |
| 2018 | 46.07 Million AUD | -18.51% |
| 2017 | 56.54 Million AUD | 231.59% |
| 2016 | 17.05 Million AUD | -7.64% |
| 2015 | 18.46 Million AUD | 57.38% |
| 2014 | 11.73 Million AUD | -21.67% |
| 2013 | 14.97 Million AUD | -35.26% |
| 2012 | 23.13 Million AUD | -11.66% |
| 2011 | 26.18 Million AUD | -11.12% |
| 2010 | 29.46 Million AUD | -11.56% |
| 2009 | 33.31 Million AUD | -35.34% |
| 2008 | 51.52 Million AUD | -9.14% |
| 2007 | 56.7 Million AUD | 29.51% |
| 2006 | 43.78 Million AUD | 33.02% |
| 2005 | 32.91 Million AUD | 11.72% |
| 2004 | 29.46 Million AUD | 18.65% |
| 2003 | 24.83 Million AUD | 5.73% |
| 2002 | 23.48 Million AUD | -3.61% |
| 2001 | 24.36 Million AUD | 60.12% |
| 2000 | 15.21 Million AUD | 108.51% |
| 1999 | 7.29 Million AUD | 62.5% |
| 1998 | 4.49 Million AUD | -18.21% |
| 1997 | 5.49 Million AUD | 39.73% |
| 1996 | 3.92 Million AUD | 83.4% |
| 1995 | 2.14 Million AUD | 0.8% |
| 1994 | 2.12 Million AUD | 29.83% |
| 1993 | 1.63 Million AUD | -1.89% |
| 1992 | 1.66 Million AUD | 26.22% |
| 1991 | 1.32 Million AUD | -13.64% |
| 1990 | 1.53 Million AUD | -37.4% |
| 1989 | 2.44 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 166.5 Million USD | 0.0% |
| 2024 FY | 188.79 Million USD | 27.4% |
| 2024 Q4 | 188.79 Million USD | 0.0% |
| 2023 FY | 148.18 Million USD | 69.7% |
| 2023 Q4 | 148.18 Million USD | 0.0% |
| 2023 Q2 | 227.1 Million USD | 0.0% |
| 2022 FY | 87.32 Million USD | -52.64% |
| 2022 Q2 | 150.22 Million USD | 0.0% |
| 2022 Q4 | 60.04 Million USD | 0.0% |
| 2021 Q2 | 213.21 Million USD | 0.0% |
| 2021 Q4 | 138.4 Million USD | 0.0% |
| 2021 FY | 184.36 Million USD | 156.46% |
| 2020 FY | 71.88 Million AUD | 90.88% |
| 2020 Q4 | 71.88 Million AUD | 0.0% |
| 2020 Q2 | 80.26 Million AUD | 0.0% |
| 2019 Q2 | 48.99 Million AUD | 0.0% |
| 2019 Q4 | 37.66 Million AUD | 0.0% |
| 2019 FY | 37.66 Million AUD | -18.26% |
| 2018 Q4 | 46.07 Million AUD | 0.0% |
| 2018 FY | 46.07 Million AUD | -18.51% |
| 2017 Q4 | 43.45 Million AUD | 0.0% |
| 2017 FY | 56.54 Million AUD | 231.59% |
| 2016 FY | 17.05 Million AUD | -7.64% |
| 2016 Q4 | 12.73 Million AUD | 0.0% |
| 2015 FY | 18.46 Million AUD | 57.38% |
| 2015 Q4 | 18.46 Million AUD | 0.0% |
| 2014 FY | 11.73 Million AUD | -21.67% |
| 2014 Q4 | 11.73 Million AUD | 0.0% |
| 2013 Q4 | 14.97 Million AUD | 0.0% |
| 2013 FY | 14.97 Million AUD | -35.26% |
| 2012 Q4 | 23.13 Million AUD | 0.0% |
| 2012 FY | 23.13 Million AUD | -11.66% |
| 2011 FY | 26.18 Million AUD | -11.12% |
| 2011 Q4 | 26.18 Million AUD | 0.0% |
| 2010 Q4 | 29.46 Million AUD | 0.0% |
| 2010 FY | 29.46 Million AUD | -11.56% |
| 2009 FY | 33.31 Million AUD | -35.34% |
| 2009 Q4 | 33.31 Million AUD | 0.0% |
| 2008 FY | 51.52 Million AUD | -9.14% |
| 2008 Q4 | 51.52 Million AUD | 0.0% |
| 2007 Q4 | 56.7 Million AUD | 0.0% |
| 2007 FY | 56.7 Million AUD | 29.51% |
| 2006 FY | 43.78 Million AUD | 33.02% |
| 2006 Q4 | 43.78 Million AUD | 0.0% |
| 2005 FY | 32.91 Million AUD | 11.72% |
| 2005 Q4 | 32.91 Million AUD | 0.0% |
| 2004 Q4 | 29.46 Million AUD | 0.0% |
| 2004 FY | 29.46 Million AUD | 18.65% |
| 2003 Q4 | 24.83 Million AUD | 0.0% |
| 2003 FY | 24.83 Million AUD | 5.73% |
| 2002 FY | 23.48 Million AUD | -3.61% |
| 2002 Q4 | 23.48 Million AUD | 0.0% |
| 2001 FY | 24.36 Million AUD | 60.12% |
| 2001 Q4 | 24.36 Million AUD | 0.0% |
| 2000 FY | 15.21 Million AUD | 108.51% |
| 2000 Q4 | 15.21 Million AUD | 0.0% |
| 1999 FY | 7.29 Million AUD | 62.5% |
| 1999 Q4 | 4.87 Million AUD | 0.0% |
| 1998 FY | 4.49 Million AUD | -18.21% |
| 1997 Q4 | 4.13 Million AUD | 0.0% |
| 1997 FY | 5.49 Million AUD | 39.73% |
| 1996 FY | 3.92 Million AUD | 83.4% |
| 1995 FY | 2.14 Million AUD | 0.8% |
| 1994 FY | 2.12 Million AUD | 29.83% |
| 1993 FY | 1.63 Million AUD | -1.89% |
| 1992 FY | 1.66 Million AUD | 26.22% |
| 1991 FY | 1.32 Million AUD | -13.64% |
| 1990 FY | 1.53 Million AUD | -37.4% |
| 1989 FY | 2.44 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -638.852% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -11195.245% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -3542.215% |
| Biome Australia Limited | 8.27 Million AUD | -2180.971% |
| Patrys Limited | 4.16 Million AUD | -4436.527% |
| Orthocell Limited | 26.61 Million AUD | -609.336% |
| Imugene Limited | 151.39 Million AUD | -24.699% |
| Noxopharm Limited | 6.78 Million AUD | -2682.989% |
| PYC Therapeutics Limited | 91.23 Million AUD | -106.92% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -1136.098% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -825.772% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -1635.993% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -2150.652% |
| CSL Limited | 56.93 Billion AUD | 99.668% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -1321.119% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -5875.181% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 18.316% |
| Starpharma Holdings Limited | 36.81 Million AUD | -412.825% |
| Nanollose Limited | 241.95 Thousand AUD | -77928.698% |
| Memphasys Limited | 12.43 Million AUD | -1418.817% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -2984.798% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -3373.062% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -1171.74% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | -67.867% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -7261.8% |
| Race Oncology Limited | 20.22 Million AUD | -833.29% |
| Nyrada Inc. | 5.9 Million AUD | -3095.917% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 52.601% |
| Dimerix Limited | 32.07 Million AUD | -488.528% |
| PharmAust Limited | 11.12 Million AUD | -1597.023% |
| Immutep Limited | 147.44 Million AUD | -28.038% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | -22.093% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -882.073% |
| BTC Health Limited | 5.14 Million AUD | -3566.698% |
| Acrux Limited | 8.96 Million AUD | -2006.34% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 23.865% |
| Biotron Limited | 493.47 Thousand AUD | -38157.426% |
| Tissue Repair Ltd | 19.38 Million AUD | -873.674% |
| AdAlta Limited | 5.57 Million AUD | -3287.604% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | -162.078% |
| Hexima Limited | 2.26 Million AUD | -8220.444% |
| AnteoTech Limited | 9.38 Million AUD | -1912.446% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -589.26% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -2863.935% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -2479.358% |
| Actinogen Medical Limited | 21.31 Million AUD | -785.85% |
| Immuron Limited | 15.54 Million AUD | -1114.094% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -1052.744% |